{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:58:17Z","timestamp":1791082697291,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["2017-02475"],"award-info":[{"award-number":["2017-02475"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.coph.2018.08.011","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T08:31:30Z","timestamp":1536654690000},"page":"66-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Mucosal permeability and mast cells as targets for functional gastrointestinal disorders"],"prefix":"10.1016","volume":"43","author":[{"given":"\u00c5sa V","family":"Keita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan D","family":"S\u00f6derholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2018.08.011_bib0005","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.phrs.2012.10.007","article-title":"Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications","volume":"69","author":"Natividad","year":"2013","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.coph.2018.08.011_bib0010","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/j.1572-0241.2006.00672.x","article-title":"Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes","volume":"101","author":"Dunlop","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2018.08.011_bib0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pain.2009.06.017","article-title":"Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome","volume":"146","author":"Zhou","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.coph.2018.08.011_bib0020","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jpeds.2008.04.062","article-title":"Increased gastrointestinal permeability and gut inflammation in children with functional abdominal pain and irritable bowel syndrome","volume":"153","author":"Shulman","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.coph.2018.08.011_bib0025","first-page":"8859","article-title":"Microbiota\u2013host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and brain\u2013gut interactions","volume":"20","author":"Hyland","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.coph.2018.08.011_bib0030","doi-asserted-by":"crossref","first-page":"e13358","DOI":"10.1111\/nmo.13358","article-title":"A GWAS meta-analysis from 5 population-based cohorts implicates ion channel genes in the pathogenesis of irritable bowel syndrome","author":"Bonfiglio","year":"2018","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.coph.2018.08.011_bib0035","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/j.gastro.2009.12.049","article-title":"Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis","volume":"138","author":"Villani","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2018.08.011_sbref0040","article-title":"Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome","author":"Zhou","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.coph.2018.08.011_bib0045","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1177\/0148607115587330","article-title":"Glutamine restores tight junction protein claudin-1 expression in colonic mucosa of patients with diarrhea-predominant irritable bowel syndrome","volume":"40","author":"Bertrand","year":"2016","journal-title":"J Parenter Enteral Nutr"},{"key":"10.1016\/j.coph.2018.08.011_bib0050","doi-asserted-by":"crossref","first-page":"G307","DOI":"10.1152\/ajpgi.00240.2001","article-title":"Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat","volume":"282","author":"Coutinho","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.coph.2018.08.011_bib0055","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1203\/PDR.0b013e3180db2949","article-title":"New insights in the etiology and pathophysiology of irritable bowel syndrome: contribution of neonatal stress models","volume":"62","author":"Barreau","year":"2007","journal-title":"Pediatr Res"},{"key":"10.1016\/j.coph.2018.08.011_bib0060","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1038\/ajg.2011.257","article-title":"The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype","volume":"106","author":"Bertiaux-Vandaele","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2018.08.011_bib0065","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/ajg.2011.472","article-title":"The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations","volume":"107","author":"Martinez","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2018.08.011_bib0070","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/ajg.2009.700","article-title":"Increased proteasome-mediated degradation of occludin in irritable bowel syndrome","volume":"105","author":"Coeffier","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2018.08.011_bib0075","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1136\/gutjnl-2016-311477","article-title":"miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea","volume":"66","author":"Martinez","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.coph.2018.08.011_bib0080","doi-asserted-by":"crossref","first-page":"244","DOI":"10.5056\/jnm.2013.19.2.244","article-title":"Mucosal mast cell count is associated with intestinal permeability in patients with diarrhea predominant irritable bowel syndrome","volume":"19","author":"Lee","year":"2013","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.coph.2018.08.011_sbref0085","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1053\/j.gastro.2017.06.051","article-title":"Vasoactive intestinal polypeptide and mast cells regulate increased passage of colonic bacteria in patients with irritable bowel syndrome","volume":"153","author":"Bednarska","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2018.08.011_bib0090","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/ajg.2013.152","article-title":"Luminal cysteine-proteases degrade colonic tight junction structure and are responsible for abdominal pain in constipation-predominant IBS","volume":"108","author":"Annahazi","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2018.08.011_bib0095","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/gutjnl-2012-303857","article-title":"Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia","volume":"63","author":"Vanheel","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.coph.2018.08.011_sbref0100","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1038\/s41598-018-23620-y","article-title":"Activation of eosinophils and mast cells in functional dyspepsia: an ultrastructural evaluation","volume":"8","author":"Vanheel","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2018.08.011_bib0105","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-230X-12-128","article-title":"Role of tight junction proteins in gastroesophageal reflux disease","volume":"12","author":"Monkemuller","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.coph.2018.08.011_bib0110","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/0016-5085(92)90177-Z","article-title":"Barriers to paracellular permeability in rabbit esophageal epithelium","volume":"102","author":"Orlando","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2018.08.011_bib0115","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1053\/gast.1996.v111.pm8898633","article-title":"Dilated intercellular spaces: a morphological feature of acid reflux\u2009\u2014\u2009damaged human esophageal epithelium","volume":"111","author":"Tobey","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2018.08.011_bib0120","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1572-0241.2005.40978.x","article-title":"Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure","volume":"100","author":"Caviglia","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2018.08.011_bib0125","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/ajg.2011.102","article-title":"Role of E-cadherin in the pathogenesis of gastroesophageal reflux disease","volume":"106","author":"Jovov","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2018.08.011_bib0130","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.humpath.2011.12.024","article-title":"Assessment of desmosomal components (desmoglein 1\u20133, plakoglobin) in cardia mucosa in relation to gastroesophageal reflux disease and Helicobacter pylori infection","volume":"43","author":"Wex","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.coph.2018.08.011_sbref0135","doi-asserted-by":"crossref","first-page":"G117","DOI":"10.1152\/ajpgi.00134.2016","article-title":"Mucosal integrity and sensitivity to acid in the proximal esophagus in patients with gastroesophageal reflux disease","volume":"311","author":"van Hoeij","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.coph.2018.08.011_bib0140","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1080\/003655299750026155","article-title":"Is the esophageal squamous epithelial barrier function impaired in patients with gastroesophageal reflux disease?","volume":"34","author":"Carlsson","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.coph.2018.08.011_bib0145","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1136\/gut.2005.064626","article-title":"Erosions or not in GORD? The potential role of oesophageal cell proliferation","volume":"54","author":"Calabrese","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.coph.2018.08.011_bib0150","first-page":"91","article-title":"Innervation of mucosal immune cells in the gastrointestinal tract","volume":"4","author":"Stead","year":"1992","journal-title":"Reg Immunol"},{"key":"10.1016\/j.coph.2018.08.011_bib0155","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000234197","article-title":"The role of mast cells in inflammatory processes: evidence for nerve\/mast cell interactions","volume":"82","author":"Bienenstock","year":"1987","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.coph.2018.08.011_bib0160","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0016-5085(89)90627-6","article-title":"Mast cells are closely apposed to nerves in the human gastrointestinal mucosa","volume":"97","author":"Stead","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2018.08.011_sbref0165","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3389\/fphys.2017.00971","article-title":"Calcium imaging of nerve-mast cell signaling in the human intestine","volume":"8","author":"Buhner","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.coph.2018.08.011_bib0170","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1365-2982.2010.01498.x","article-title":"The intestinal barrier and its regulation by neuroimmune factors","volume":"22","author":"Keita","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.coph.2018.08.011_bib0175","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13007","article-title":"Neuroimmune factors in functional gastrointestinal disorders: a focus on irritable bowel syndrome","volume":"29","author":"Boeckxstaens","year":"2017","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.coph.2018.08.011_bib0180","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.1111\/nmo.12127","article-title":"Vasoactive intestinal polypeptide regulates barrier function via mast cells in human intestinal follicle-associated epithelium and during stress in rats","volume":"25","author":"Keita","year":"2013","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.coph.2018.08.011_bib0185","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1136\/gutjnl-2013-305690","article-title":"Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism","volume":"63","author":"Vanuytsel","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.coph.2018.08.011_bib0190","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/ibd\/izx002","article-title":"A beta-glucan-based dietary fiber reduces mast cell-induced hyperpermeability in ileum from patients with Crohn\u2019s disease and control subjects","volume":"24","author":"Ganda Mall","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.coph.2018.08.011_bib0195","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1053\/j.gastro.2011.01.042","article-title":"Eosinophils express muscarinic receptors and corticotropin-releasing factor to disrupt the mucosal barrier in ulcerative colitis","volume":"140","author":"Wallon","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2018.08.011_bib0200","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00281-009-0165-4","article-title":"Physiological and pathophysiological functions of intestinal mast cells","volume":"31","author":"Bischoff","year":"2009","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.coph.2018.08.011_bib0205","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1196\/annals.1443.023","article-title":"Mast cells: multifaceted immune cells with diverse roles in health and disease","volume":"1143","author":"Rao","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.coph.2018.08.011_bib0210","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1242\/jcs.112.1.137","article-title":"Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29\/B6","volume":"112","author":"Schmitz","year":"1999","journal-title":"J Cell Sci"},{"key":"10.1016\/j.coph.2018.08.011_bib0215","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1096\/fj.99-0898com","article-title":"Leaks in the epithelial barrier caused by spontaneous and TNF-alpha-induced single-cell apoptosis","volume":"14","author":"Gitter","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.coph.2018.08.011_bib0220","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/gut.2006.100594","article-title":"Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum","volume":"56","author":"Guilarte","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.coph.2018.08.011_bib0225","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/ajg.2008.94","article-title":"Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms","volume":"104","author":"Cremon","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2018.08.011_bib0230","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/j.gastro.2003.11.055","article-title":"Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome","volume":"126","author":"Barbara","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2018.08.011_bib0235","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/gut.2007.127068","article-title":"Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome","volume":"57","author":"Piche","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.coph.2018.08.011_bib0240","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/ajg.2010.151","article-title":"Migration of eosinophils and CCR2-\/CD68-double positive cells into the duodenal mucosa of patients with postinfectious functional dyspepsia","volume":"105","author":"Futagami","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2018.08.011_bib0245","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/0333102412472070","article-title":"Relationship between headache and mucosal mast cells in pediatric Helicobacter pylori-negative functional dyspepsia","volume":"33","author":"Yeom","year":"2013","journal-title":"Cephalalgia"},{"key":"10.1016\/j.coph.2018.08.011_bib0250","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.anndiagpath.2015.02.001","article-title":"Quantitative evaluation of duodenal eosinophils and mast cells in adult patients with functional dyspepsia","volume":"19","author":"Wang","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.coph.2018.08.011_bib0255","doi-asserted-by":"crossref","first-page":"34305","DOI":"10.1038\/srep34305","article-title":"Increased duodenal eosinophil degranulation in patients with functional dyspepsia: a prospective study","volume":"6","author":"Du","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2018.08.011_bib0260","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/gast.1996.v110.pm8536848","article-title":"Mast cells mediate acid-induced augmentation of opossum esophageal blood flow via histamine and nitric oxide","volume":"110","author":"Feldman","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2018.08.011_bib0265","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1210\/en.2006-0565","article-title":"Identification and characterization of multiple corticotropin-releasing factor type 2 receptor isoforms in the rat esophagus","volume":"148","author":"Wu","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.coph.2018.08.011_bib0270","doi-asserted-by":"crossref","first-page":"G34","DOI":"10.1152\/ajpgi.00068.2009","article-title":"TRPA1 in mast cell activation-induced long-lasting mechanical hypersensitivity of vagal afferent C-fibers in guinea pig esophagus","volume":"297","author":"Yu","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.coph.2018.08.011_bib0275","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/1751-2980.12226","article-title":"Mast cell activation is involved in stress-induced epithelial barrier dysfunction in the esophagus","volume":"16","author":"Zhong","year":"2015","journal-title":"J Dig Dis"},{"key":"10.1016\/j.coph.2018.08.011_bib0280","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1038\/ajg.2010.265","article-title":"Proteinase-activated receptor-2 in the pathogenesis of gastroesophageal reflux disease","volume":"105","author":"Kandulski","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2018.08.011_bib0285","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doy039","article-title":"Developing a diagnostic understanding of GERD phenotypes through the analysis of levels of mucosal injury, immune activation, and psychological comorbidity","author":"Zhong","year":"2018","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.coph.2018.08.011_bib0290","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/gut.2006.117549","article-title":"Corticotropin-releasing hormone (CRH) regulates macromolecular permeability via mast cells in normal human colonic biopsies in vitro","volume":"57","author":"Wallon","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.coph.2018.08.011_bib0295","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2036.2009.04041.x","article-title":"Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study","volume":"30","author":"Corinaldesi","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2018.08.011_bib0300","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/gut.2010.213108","article-title":"The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome","volume":"59","author":"Klooker","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.coph.2018.08.011_sbref0305","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1177\/2050640617691690","article-title":"Downregulation of mucosal mast cell activation and immune response in diarrhoea-irritable bowel syndrome by oral disodium cromoglycate: a pilot study","volume":"5","author":"Lobo","year":"2017","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.coph.2018.08.011_bib0310","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/000992280604500205","article-title":"Mucosal eosinophilia and response to H1\/H2 antagonist and cromolyn therapy in pediatric dyspepsia","volume":"45","author":"Friesen","year":"2006","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.coph.2018.08.011_bib0315","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1365-2982.2010.01471.x","article-title":"Stress-induced barrier disruption of rat follicle-associated epithelium involves corticotropin-releasing hormone, acetylcholine, substance P, and mast cells","volume":"22","author":"Keita","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.coph.2018.08.011_sbref0320","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1189\/jlb.2HI0317-088RR","article-title":"Frontline science: corticotropin-releasing factor receptor subtype 1 is a critical modulator of mast cell degranulation and stress-induced pathophysiology","volume":"102","author":"Ayyadurai","year":"2017","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.coph.2018.08.011_bib0325","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.09.049","article-title":"Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome","volume":"152","author":"Tap","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2018.08.011_bib0330","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(17)30338-2","article-title":"Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial","volume":"3","author":"Johnsen","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2018.08.011_bib0335","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000488773","article-title":"Dysbiosis in functional bowel disorders","volume":"72","author":"Enck","year":"2018","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.coph.2018.08.011_sbref0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40139-018-0160-3","article-title":"Targeting the microbiota, from irritable bowel syndrome to mood disorders: focus on probiotics and prebiotics","volume":"6","author":"Pusceddu","year":"2018","journal-title":"Curr Pathobiol Rep"},{"key":"10.1016\/j.coph.2018.08.011_bib0345","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/2050640617736478","article-title":"Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: a pilot randomized clinical trial","volume":"6","author":"Cremon","year":"2018","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.coph.2018.08.011_bib0350","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1136\/gut.2005.080739","article-title":"Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress","volume":"55","author":"Zareie","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.coph.2018.08.011_bib0355","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13069","article-title":"L. fermentum CECT 5716 prevents stress-induced intestinal barrier dysfunction in newborn rats","volume":"29","author":"Vanhaecke","year":"2017","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.coph.2018.08.011_bib0360","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bbi.2017.05.011","article-title":"Bifidobacterium CECT 7765 modulates early stress-induced immune, neuroendocrine and behavioral alterations in mice","volume":"65","author":"Moya-Perez","year":"2017","journal-title":"Brain Behav Immun"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489218300717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489218300717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:49:54Z","timestamp":1761461394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489218300717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":72,"alternative-id":["S1471489218300717"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2018.08.011","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucosal permeability and mast cells as targets for functional gastrointestinal disorders","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2018.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}